BioSpace News Archive

FluGen Inc., announced today that it has been awarded a grant of $14.4 million through the DOD’s Congressionally Directed Medical Research Programs Peer Reviewed Medical Research Program’s (PRMRP) mechanism to conduct clinical challenge-studies against mismatched influenza strains with its lead universal flu vaccine, RedeeFlu.

Entatio today announced the release of Entatio for Pharma, a cloud application built specifically for pharmaceutical and medical device companies to aid in the delivery of highly regulated medical content to physicians through medical conferences and events.

Company Remains on-track to submit 510(k) application in 2017.

Results were published this week in the Journal of the American Medical Association Psychiatry.

Radius plans to initiate Phase 2 clinical study of elacestrant as a third-line therapy for women with ER+ and HER2- breast cancer early in 2018.

Asymchem today announced that its API facility, Jilin Asymchem Laboratories Co., Ltd. in P.R. China, (“Dunhua”), has successfully passed an inspection by the Australian Therapeutic Goods Administration (TGA) for the second consecutive time.

BioMarin updated the investment community on the Company’s development portfolio at R&D Day in New York.

The enormity of changes in the field of medical imaging technology is hard to fathom.

Conclusions will be presented at the American Thyroid Association annual meeting.

Conference call to be conducted same day at 4:30 pm ET.